United States Pharmacopeia (USP) Safety Review of Gamma-Aminobutyric Acid (GABA)

Gamma-amino butyric acid (GABA) is marketed in the U.S. as a dietary supplement. USP conducted a comprehensive safety evaluation of GABA by assessing clinical studies, adverse event information, and toxicology data. Clinical studies investigated the effect of pure GABA as a dietary supplement or as...

Descripción completa

Detalles Bibliográficos
Autores principales: Oketch-Rabah, Hellen A., Madden, Emily F., Roe, Amy L., Betz, Joseph M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399837/
https://www.ncbi.nlm.nih.gov/pubmed/34444905
http://dx.doi.org/10.3390/nu13082742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399837/
https://www.ncbi.nlm.nih.gov/pubmed/34444905
http://dx.doi.org/10.3390/nu13082742

Ejemplares similares